Clinical Trials List
Protocol NumberCSL964_2001
Completed
2025-12-01 - 2030-04-19
Phase II/III
Recruiting2
ICD-10D75.1
Secondary polycythemia
ICD-9289.0
Polycythemia, secondary
-
Trial Applicant
Syneos Health
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- 陳珈妤 Division of Hematology & Oncology
- 王幸婷 Division of Hematology & Oncology
- 鄭富銘 Division of Hematology & Oncology
- Ming-Yu Lien Division of Hematology & Oncology
- Che-Hung Lin Division of Hematology & Oncology
- Chi-Ching Chen Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Tai-Chung Huang Division of Hematology & Oncology
- 林明恩 Division of Hematology & Oncology
- Huai-Hsuan Huang Division of Hematology & Oncology
- CHENG-HONG TSAI Division of Hematology & Oncology
- Chieh-Lung Cheng Division of Hematology & Oncology
- Chien-Chin Lin Division of Hematology & Oncology
- 李思慧 Division of Hematology & Oncology
- HSIN-AN HOU Division of Hematology & Oncology
- 田豐銘 Division of Hematology & Oncology
- MING YAO Division of Hematology & Oncology
- Wen-Chien Chou Division of Hematology & Oncology
- 楊鎰聰 Division of Hematology & Oncology
- YAO CHI-YUAN Division of Others -
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
25 participants
-
Global
310 participants
